ABBV vs MRK: Valuation Comparison 2026
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Side-by-side fundamentals for AbbVie Inc. (ABBV) and Merck & Co., Inc. (MRK) — market cap, PE, PEG and sector. All figures from SEC filings and market data.
| Metric | ABBV | MRK |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Current Price (Cboe, delayed) | $284.8 | $149.88 |
| Market Cap | $503.28B | $369.78B |
| PE Ratio | 80.23 | 118.02 |
| PEG Ratio | — | 5.65 |
| PEG Verdict | N/A | PEG above 2.0 |